Fujihara K - Search Results

1

Expression of OX40 and OX40 ligand (gp34) in the normal and myasthenic thymus.

Onodera J, Nagata T, Fujihara K, Ohuchi M, Ishii N, Sugamura K, Itoyama Y. Onodera J, et al. Among authors: fujihara k. Acta Neurol Scand. 2000 Oct;102(4):236-43. doi: 10.1034/j.1600-0404.2000.102004236.x. Acta Neurol Scand. 2000. PMID: 11071109

2

Decreased expression of c-myc family genes in thymuses from myasthenia gravis patients.

Nagata T, Onodera H, Ohuchi M, Suzuki Y, Tago H, Fujihara K, Ishii N, Sugamura K, Shoji Y, Handa M, Tabayashi K, Itoyama Y. Nagata T, et al. Among authors: fujihara k. J Neuroimmunol. 2001 Apr 2;115(1-2):199-202. doi: 10.1016/s0165-5728(01)00252-1. J Neuroimmunol. 2001. PMID: 11282171 Clinical Trial.

3

Relevance of callosal and periventricular MRI lesions to oligoclonal bands in multiple sclerosis.

Nakashima I, Fujihara K, Miyazawa H, Misu T, Fujimori J, Sato S, Itoyama Y. Nakashima I, et al. Among authors: fujihara k. Acta Neurol Scand. 2006 Feb;113(2):125-31. doi: 10.1111/j.1600-0404.2005.00552.x. Acta Neurol Scand. 2006. PMID: 16411974

4

[A juvenile case of Lambert-Eaton myasthenic syndrome with severe emaciation].

Nakashima I, Kikuchi A, Onodera J, Shiga Y, Fujihara K, Motomura M, Itoyama Y. Nakashima I, et al. Among authors: fujihara k. Rinsho Shinkeigaku. 1997 May;37(5):402-6. Rinsho Shinkeigaku. 1997. PMID: 9294328 Japanese.

5

Complement activation as a cause of transient hypotension during plasmapheresis.

Shiga Y, Fujihara K, Onodera H, Nagata T, Itoyama Y. Shiga Y, et al. Among authors: fujihara k. Artif Organs. 1998 Dec;22(12):1067-9. doi: 10.1046/j.1525-1594.1998.06170.x. Artif Organs. 1998. PMID: 9876101

6

[Steroid-responsive diffuse cerebral white matter lesions in a case of intractable fungal meningoencephalitis].

Suzuki Y, Onodera J, Sakuma R, Shiga Y, Fujihara K, Konno H, Itoyama Y. Suzuki Y, et al. Among authors: fujihara k. No To Shinkei. 1999 Jan;51(1):69-74. No To Shinkei. 1999. PMID: 10065464 Japanese.

7

Oligoclonal IgG bands in Japanese multiple sclerosis patients.

Nakashima I, Fujihara K, Itoyama Y. Nakashima I, et al. Among authors: fujihara k. J Neuroimmunol. 1999 Nov 15;101(2):205-6. doi: 10.1016/s0165-5728(99)00147-2. J Neuroimmunol. 1999. PMID: 10580804 No abstract available.

8

Elevated plasma level of plasminogen activator inhibitor-1 (PAI-1) in patients with relapsing-remitting multiple sclerosis.

Onodera H, Nakashima I, Fujihara K, Nagata T, Itoyama Y. Onodera H, et al. Among authors: fujihara k. Tohoku J Exp Med. 1999 Dec;189(4):259-65. doi: 10.1620/tjem.189.259. Tohoku J Exp Med. 1999. PMID: 10739162 Free article.

9

Optic-spinal form of multiple sclerosis and immune-mediated myelopathy in Japan.

Fujihara K, Nakashima I, Itoyama Y. Fujihara K, et al. J Neural Transm Suppl. 2000;(58):205-14. doi: 10.1007/978-3-7091-6284-2_17. J Neural Transm Suppl. 2000. PMID: 11128610 Review.

10

Human parvovirus B19 infection in multiple sclerosis.

Nakashima I, Fujihara K, Itoyama Y. Nakashima I, et al. Among authors: fujihara k. Eur Neurol. 1999 Jul;42(1):36-40. doi: 10.1159/000008066. Eur Neurol. 1999. PMID: 10394046

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

605 results

Search Page

Filters